Eterna Therapeutics Inc.(ERNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ERNA Eterna Therapeutics Inc.

交易中 10-08 09:33:15 EDT

2.39

+0.00

0.00%

最高2.39	最低2.39	成交量4.76万
今开2.39	昨收2.39	日振幅0.00%
总市值390.14万	流通市值290.53万	总股本163.24万
成交额11.40万	换手率3.91%	流通股本121.56万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ERNA","market":"US","secType":"STK","nameCN":"Eterna Therapeutics Inc.","latestPrice":2.39,"timestamp":1791466290968,"preClose":2.39,"halted":0,"volume":47558,"delay":0,"changeRate":0,"floatShares":1215600,"shares":1632400,"eps":-18.605883,"marketStatus":"交易中","change":0,"latestTime":"10-08 09:33:15 EDT","open":2.39,"high":2.39,"low":2.39,"amount":114015.3970144,"amplitude":0,"askPrice":2.57,"askSize":136,"bidPrice":2.39,"bidSize":6783,"shortable":3,"etf":0,"ttmEps":-18.605883,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"listingDate":465451200000,"exchange":"NASDAQ","adjPreClose":2.39,"preHourTrading":{"tag":"盘前","latestPrice":2.38,"preClose":2.39,"latestTime":"09:29 EDT","volume":29024,"amount":68153.373152,"timestamp":1791466199090,"change":-0.01,"changeRate":-0.004184,"amplitude":0.121339},"postHourTrading":{"tag":"盘后","latestPrice":2.58,"preClose":2.39,"latestTime":"19:59 EDT","volume":637903,"amount":1779543.1706,"timestamp":1791417582713,"change":0.19,"changeRate":0.079498,"amplitude":0.398285},"volumeRatio":27.193499},"requestUrl":"/m/hq/s/ERNA","defaultTab":"news","newsList":[{"id":"1142217030","title":"Ernexa Therapeutics——旨在拓展肿瘤学项目并推进下一代IMSC候选方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1142217030","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142217030?lang=zh_cn&edition=full","pubTime":"2026-09-15 20:44","pubTimestamp":1789476267,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics透露，其计划扩大肿瘤学研发版图，同时加速推进新一代诱导多能干细胞（IMSC）候选疗法的开发进程。此举标志着公司在精准医疗和癌症治疗领域的战略布局正迈向更深层次。当前，该企业正积极整合资源，力求在竞争激烈的生物制药赛道中占据有利位置。通过聚焦于创新疗法的迭代升级，Ernexa希望攻克现有治疗方案的局限性，为患者带来更具针对性的选择。此番动作，无疑将为其后续临床管线注入强劲动力，也引发了业内对IMSC技术应用前景的新一轮关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175196838","title":"Ernexa Therapeutics公布Erna-201临床前积极数据，展现疾病修饰潜力，强化iMSC平台实力，加速肿瘤学战略及Erna-101迈向首次人体给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1175196838","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175196838?lang=zh_cn&edition=full","pubTime":"2026-09-15 20:43","pubTimestamp":1789476205,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics今日宣布，其候选药物Erna-201的临床前研究数据呈现出积极的疾病修饰效应，这一成果有力地印证了公司旗下iMSC平台的强大潜力。与此同时，公司正全力推进其肿瘤学战略布局，并加速将另一核心管线资产Erna-101推向首次人体给药的关键阶段。公司管理层表示，随着肿瘤学战略的持续深化，Erna-101的研发进程也在同步提速。该候选药物目前正朝着首次人体给药的目标稳步迈进，这标志着Ernexa Therapeutics在将前沿科学转化为切实疗法方面又迈出了至关重要的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160775739","title":"Ernexa Therapeutics推进ERNA-101，剑指铂耐药卵巢癌IND申报","url":"https://stock-news.laohu8.com/highlight/detail?id=1160775739","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160775739?lang=zh_cn&edition=full","pubTime":"2026-09-15 20:43","pubTimestamp":1789476196,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics宣布，将积极推进其候选药物ERNA-101，目标直指铂耐药性卵巢癌的临床试验申请（IND）提交。这一战略举措，彰显了公司在肿瘤治疗领域的坚定决心与前瞻布局。目前，该公司正全力加速相关研发进程，力求早日为患者带来新的治疗希望。此举，也被业界视为其深耕精准医疗的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193258586","title":"新闻稿：Ernexa Therapeutics 引入资深生物技术高管 David Polinsky 加入董事会，为临床阶段冲刺蓄力","url":"https://stock-news.laohu8.com/highlight/detail?id=1193258586","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193258586?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:09","pubTimestamp":1786367399,"startTime":"0","endTime":"0","summary":"此次任命正值公司关键转折点，进一步强化了其领导团队——Ernexa 正全力推进其核心项目 ERNA-101，计划于2026年第三季度提交新药临床试验申请，并在第四季度启动首项一期临床研究。马萨诸塞州剑桥市，2026年8月10日——Ernexa Therapeutics，一家致力于开发创新细胞疗法以治疗晚期癌症和自身免疫性疾病的行业先锋，今日宣布任命 David Polinsky 为其董事会成员。“我们正步入 Ernexa 历史上最为重要的时期之一，”Ernexa Therapeutics 总裁兼首席执行官 Sanjeev Luther 表示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","BK4205","ERNA","RFL","BK4588","LENZ","BK4585","BK4539","IND","BK4581","XBI","IBB","SYNB","BK4233","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152961172","title":"Ernexa Therapeutics首席执行官强调差异化Erna-101平台，公司计划于2026年启动首次人体一期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1152961172","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152961172?lang=zh_cn&edition=full","pubTime":"2026-07-14 21:18","pubTimestamp":1784035119,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics首席执行官在最新访谈中重点介绍了其独特的Erna-101平台，该公司正稳步推进计划于2026年启动的首次人体一期临床研究。\n该平台展现出显著的差异化优势，为后续临床试验奠定了坚实基础。随着研发进程的深入，公司致力于在明年实现这一重要里程碑。\n首席执行官详细阐述了平台的技术特点与创新机制，强调其在治疗领域的潜在突破性。研究团队正积极筹备相关试验工作，确保符合监管要求与科学标准。\n行业观察人士对此进展表示关注，认为该平台的推进可能为相关疾病治疗带来新的方向。公司将继续公布研发节点信息，保持与科学界及投资界的透明沟通。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227115","title":"Eterna Therapeutics Inc.盘中异动 快速下挫5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227115?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:48","pubTimestamp":1741614503,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时48分，Eterna Therapeutics Inc.股票出现异动，股价快速下挫5.15%。截至发稿，该股报0.271美元/股，成交量9913股，换手率0.02%，振幅0.98%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2661.00%、604.15%、92.35%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214823a26a2b3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214823a26a2b3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ERNA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517186621","title":"Eterna Therapeutics Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517186621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517186621?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:50","pubTimestamp":1741294233,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时50分，Eterna Therapeutics Inc.股票出现异动，股价快速上涨5.23%。截至发稿，该股报0.300美元/股，成交量5.3505万股，换手率0.10%，振幅8.91%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.02%。其相关个股中，Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为5427.26%、5359.77%、280.61%，振幅较大的相关个股有Plus Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Tonix Pharmaceuticals Holding Corp.，振幅分别为306.80%、127.10%、71.44%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045033989ef4b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045033989ef4b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516670409","title":"Eterna Therapeutics Inc.盘中异动 股价大跌6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516670409?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:57","pubTimestamp":1741100240,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时57分，Eterna Therapeutics Inc.股票出现波动，股价急速下挫6.77%。截至发稿，该股报0.260美元/股，成交量8.5642万股，换手率0.17%，振幅3.23%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1148.61%、1120.17%、547.46%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Celularity Inc C/Wts 16/07/2026 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为44.32%、37.67%、34.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225720989bb3d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225720989bb3d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ERNA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516655902","title":"Eterna Therapeutics Inc.盘中异动 早盘急速下跌6.88%报0.283美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516655902?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:24","pubTimestamp":1741019081,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时24分，Eterna Therapeutics Inc.股票出现波动，股价急速下挫6.88%。截至发稿，该股报0.283美元/股，成交量5.3856万股，换手率0.10%，振幅3.13%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3748.47%、166.95%、140.50%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Radiopharm Theranostics Limited，振幅分别为206.20%、70.53%、53.50%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304002441abe65764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304002441abe65764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514332025","title":"Eterna Therapeutics Inc.盘中异动 临近收盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514332025?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:42","pubTimestamp":1740688957,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时42分，Eterna Therapeutics Inc.股票出现波动，股价急速下挫5.08%。截至发稿，该股报0.280美元/股，成交量10.6788万股，换手率0.21%，振幅5.93%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1942.80%、409.95%、197.12%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280442389895539f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280442389895539f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514885664","title":"Eterna Therapeutics Inc.盘中异动 早盘股价大涨12.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514885664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514885664?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580341,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Eterna Therapeutics Inc.股票出现异动，股价快速拉升12.44%。截至发稿，该股报0.330美元/股，成交量2.5469万股，换手率0.05%，振幅10.19%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2829.37%、119.05%、90.31%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为35.59%、16.86%、14.35%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223221a254f6a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223221a254f6a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514016384","title":"Eterna Therapeutics Inc.盘中异动 早盘股价大跌6.04%报0.283美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514016384?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:30","pubTimestamp":1740497417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时30分，Eterna Therapeutics Inc.股票出现波动，股价快速下挫6.04%。截至发稿，该股报0.283美元/股，成交量5.8695万股，换手率0.11%，振幅2.99%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1070.68%、947.53%、593.23%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、64.05%、61.16%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233018abdc8d61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233018abdc8d61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514775489","title":"Eterna Therapeutics Inc.盘中异动 早盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514775489?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:54","pubTimestamp":1740412484,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时54分，Eterna Therapeutics Inc.股票出现异动，股价快速下挫5.34%。截至发稿，该股报0.298美元/股，成交量4.8094万股，换手率0.09%，振幅10.07%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为233.69%、100.01%、28.36%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为151.09%、55.69%、53.34%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235444a2522804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235444a2522804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512800764","title":"Eterna Therapeutics Inc.盘中异动 急速上涨7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512800764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512800764?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:54","pubTimestamp":1739987667,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时54分，Eterna Therapeutics Inc.股票出现异动，股价急速拉升7.39%。截至发稿，该股报0.325美元/股，成交量19.427万股，换手率0.38%，振幅7.69%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为647.24%、251.00%、218.65%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为250.83%、159.49%、52.00%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220015427988b51e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220015427988b51e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166477","title":"Eterna Therapeutics Inc.盘中异动 早盘快速下挫5.05%报0.292美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512166477?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889152,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Eterna Therapeutics Inc.股票出现异动，股价急速跳水5.05%。截至发稿，该股报0.292美元/股，成交量1.9698万股，换手率0.04%，振幅1.30%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Glycomimetics, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为278.93%、95.15%、69.45%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Solid Biosciences Inc.，振幅分别为34.04%、22.30%、18.61%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223232a24aacd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223232a24aacd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511918506","title":"Eterna Therapeutics Inc.股价飙升11.15% 市值涨128.26万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511918506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511918506?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543474,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Eterna Therapeutics Inc.股票出现波动，股价急速拉升11.15%。截至发稿，该股报0.320美元/股，成交量8.6397万股，换手率0.17%，振幅0.00%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Os Therapies Incorporated涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为975.60%、349.19%、314.94%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Os Therapies Incorporated、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、14.07%、10.73%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422311596231b35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422311596231b35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511952101","title":"Eterna Therapeutics Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511952101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511952101?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:32","pubTimestamp":1739460759,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时32分，Eterna Therapeutics Inc.股票出现异动，股价急速上涨5.07%。截至发稿，该股报0.275美元/股，成交量10.8772万股，换手率0.21%，振幅3.85%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Edesa Biotech, Inc.、Dominari Holdings Inc.、Enanta Pharmaceuticals, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2327.78%、1136.84%、153.75%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233239abcdbe16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233239abcdbe16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ERNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510338107","title":"Eterna Therapeutics Inc.盘中异动 急速跳水7.12%报0.300美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510338107?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:00","pubTimestamp":1739286006,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时00分，Eterna Therapeutics Inc.股票出现波动，股价大幅跳水7.12%。截至发稿，该股报0.300美元/股，成交量3.2239万股，换手率0.06%，振幅3.34%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2441.55%、684.26%、307.69%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical, Inc.，振幅分别为45.29%、37.99%、33.04%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211230006a2420127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211230006a2420127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510665868","title":"Eterna Therapeutics Inc.盘中异动 股价大跌8.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510665868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510665868?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:57","pubTimestamp":1739199450,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时57分，Eterna Therapeutics Inc.股票出现异动，股价急速跳水8.34%。截至发稿，该股报0.308美元/股，成交量2.2879万股，换手率0.04%，振幅7.39%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2246.85%、1420.72%、828.60%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为59.71%、51.99%、39.57%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225730abc9abbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225730abc9abbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ERNA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509742094","title":"Eterna Therapeutics Inc.盘中异动 早盘股价大涨5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509742094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509742094?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:50","pubTimestamp":1738939840,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时50分，Eterna Therapeutics Inc.股票出现异动，股价快速上涨5.91%。截至发稿，该股报0.360美元/股，成交量10.8683万股，换手率0.21%，振幅5.47%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2757.86%、61.72%、59.18%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、29.45%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225040987db11e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225040987db11e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ernexatx.com","stockEarnings":[{"period":"1week","weight":-0.2531},{"period":"1month","weight":-0.4455},{"period":"3month","weight":-0.597},{"period":"6month","weight":-0.51},{"period":"1year","weight":-0.927},{"period":"ytd","weight":-0.9203}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ernexa Therapeutics Inc于1984年在特拉华州注册成立。Ernexa是一家晚期临床阶段的生物制药公司，专注于治疗癌症患者的基于IL-2细胞因子的疗法。Ernexa致力于开发IRX-2，一种基于细胞因子的新型疗法，用于治疗癌症患者。IRX-2活性成分，即IL-2和其他关键细胞因子，被假定为信号、增强和恢复被肿瘤抑制的免疫功能，从而使免疫系统能够攻击癌细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.558824,"avgChangeRate":0.130666},{"month":2,"riseRate":0.382353,"avgChangeRate":-0.039626},{"month":3,"riseRate":0.558824,"avgChangeRate":0.018953},{"month":4,"riseRate":0.352941,"avgChangeRate":0.335049},{"month":5,"riseRate":0.411765,"avgChangeRate":0.015195},{"month":6,"riseRate":0.5,"avgChangeRate":0.005635},{"month":7,"riseRate":0.257143,"avgChangeRate":-0.04689},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.016811},{"month":9,"riseRate":0.314286,"avgChangeRate":-0.035612},{"month":10,"riseRate":0.342857,"avgChangeRate":-0.047285},{"month":11,"riseRate":0.5,"avgChangeRate":0.055021},{"month":12,"riseRate":0.323529,"avgChangeRate":-0.050712}],"exchange":"NASDAQ","name":"Eterna Therapeutics Inc.","nameEN":"Eterna Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eterna Therapeutics Inc.(ERNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Eterna Therapeutics Inc.(ERNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Eterna Therapeutics Inc.,ERNA,Eterna Therapeutics Inc.股票,Eterna Therapeutics Inc.股票老虎,Eterna Therapeutics Inc.股票老虎国际,Eterna Therapeutics Inc.行情,Eterna Therapeutics Inc.股票行情,Eterna Therapeutics Inc.股价,Eterna Therapeutics Inc.股市,Eterna Therapeutics Inc.股票价格,Eterna Therapeutics Inc.股票交易,Eterna Therapeutics Inc.股票购买,Eterna Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eterna Therapeutics Inc.(ERNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Eterna Therapeutics Inc.(ERNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}